{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:43:49Z","timestamp":1782276229618,"version":"3.54.5"},"reference-count":20,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>We leveraged genetic variants associated with caffeine metabolism in the two-sample Mendelian randomization framework to investigate the effect of plasma caffeine levels on the risk of Alzheimer\u2019s disease and Parkinson\u2019s disease. Genetic association estimates for the outcomes were obtained from the International Genomics of Alzheimer\u2019s Project, the International Parkinson\u2019s Disease Genomics consortium, the FinnGen consortium, and the UK Biobank. Genetically predicted higher plasma caffeine levels were associated with a non-significant lower risk of Alzheimer\u2019s disease (odds ratio 0.87; 95% confidence interval 0.76, 1.00; p = 0.056). A suggestive association was observed for genetically predicted higher plasma caffeine levels and lower risk of Parkinson\u2019s disease in the FinnGen consortium. but not in the International Parkinson\u2019s Disease Genomics consortium; no overall association was found (odds ratio 0.92; 95% confidence interval 0.77, 1.10; p = 0.347). This study found possible suggestive evidence of a protective role of caffeine in Alzheimer\u2019s disease. The association between caffeine and Parkinson\u2019s disease requires further study.<\/jats:p>","DOI":"10.3390\/nu14091697","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:22:43Z","timestamp":1650414163000},"page":"1697","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Plasma Caffeine Levels and Risk of Alzheimer\u2019s Disease and Parkinson\u2019s Disease: Mendelian Randomization Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-0341","authenticated-orcid":false,"given":"Susanna C.","family":"Larsson","sequence":"first","affiliation":[{"name":"Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, SE-751 85 Uppsala, Sweden"},{"name":"Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1505-2570","authenticated-orcid":false,"given":"Benjamin","family":"Woolf","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit, University of Bristol, Bristol BS8 2BN, UK"},{"name":"School of Psychological Science, University of Bristol, Bristol BS8 1TU, UK"},{"name":"Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7312-7078","authenticated-orcid":false,"given":"Dipender","family":"Gill","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1NY, UK"},{"name":"Department of Clinical Pharmacology and Therapeutics, Institute for Infection and Immunity, St George\u2019s, University of London, London SW17 0RE, UK"},{"name":"Genetics Department, Novo Nordisk Research Centre Oxford, Old Road Campus, Oxford OX3 7FZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.01.083","article-title":"Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review","volume":"101","year":"2014","journal-title":"Life Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Larsson, S.C., and Orsini, N. (2018). Coffee Consumption and Risk of Dementia and Alzheimer\u2019s Disease: A Dose-Response Meta-Analysis of Prospective Studies. Nutrients, 10.","DOI":"10.3390\/nu10101501"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.3233\/JAD-2010-091525","article-title":"Caffeine exposure and the risk of Parkinson\u2019s disease: A systematic review and meta-analysis of observational studies","volume":"20","author":"Costa","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"ref_4","first-page":"5472","article-title":"Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior","volume":"25","author":"Cornelis","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: A meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_7","unstructured":"(2022, February 01). FinnGen Study. Data Freeze 6 Results and Summary Statistics. Available online: https:\/\/finngen.gitbook.io\/documentation\/."},{"key":"ref_8","unstructured":"Mitchell, R., Elsworth, B.L., Mitchell, R., Raistrick, C.A., Paternoster, L., Hemani, G., and Gaunt, T.R. (2022, March 17). MRC IEU UK Biobank GWAS Pipeline Version 2, Faculty of Health Sciences. Available online: https:\/\/data.bris.ac.uk\/data\/dataset\/pnoat8cxo0u52p6ynfaekeigi."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-2012-111781","article-title":"High blood caffeine levels in MCI linked to lack of progression to dementia","volume":"30","author":"Cao","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"744872","DOI":"10.3389\/fnagi.2021.744872","article-title":"Higher coffee consumption is associated with slower cognitive decline and less cerebral Abeta-amyloid accumulation over 126 months: Data from the Australian Imaging, Biomarkers, and Lifestyle Study","volume":"13","author":"Gardener","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41398-019-0604-5","article-title":"Coffee intake and decreased amyloid pathology in human brain","volume":"9","author":"Kim","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.foodchem.2018.01.075","article-title":"NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts","volume":"252","author":"Ciaramelli","year":"2018","journal-title":"Food Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s13311-018-0669-5","article-title":"L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer\u2019s Disease","volume":"15","author":"Polis","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1152\/physrev.00037.2016","article-title":"Arginase: A Multifaceted Enzyme Important in Health and Disease","volume":"98","author":"Caldwell","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Avitan, I., Halperin, Y., Saha, T., Bloch, N., Atrahimovich, D., Polis, B., Samson, A.O., and Braitbard, O. (2021). Towards a consensus on Alzheimer\u2019s disease comorbidity?. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194360"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"j5375","DOI":"10.1136\/bmj.j5375","article-title":"Modifiable pathways in Alzheimer\u2019s disease: Mendelian randomisation analysis","volume":"359","author":"Larsson","year":"2017","journal-title":"BMJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3233\/JAD-210678","article-title":"Genetically Predicted Coffee Consumption and Risk of Alzheimer\u2019s Disease and Stroke","volume":"83","author":"Zhang","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2022.03.022","article-title":"Self-reported and genetically predicted coffee consumption and smoking in dementia: A Mendelian randomization study","volume":"348","author":"Nordestgaard","year":"2022","journal-title":"Atherosclerosis"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Cornelis, M.C., and Munafo, M.R. (2018). Mendelian Randomization Studies of Coffee and Caffeine Consumption. Nutrients, 10.","DOI":"10.3390\/nu10101343"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/JPD-212851","article-title":"Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson\u2019s Disease","volume":"12","author":"Domenighetti","year":"2022","journal-title":"J. Parkinsons Dis."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/9\/1697\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:57:02Z","timestamp":1760137022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/9\/1697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["nu14091697"],"URL":"https:\/\/doi.org\/10.3390\/nu14091697","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]}}}